Brain Scientific Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - USD ($)			1 Months Ended		3 Months Ended		12 Months Ended
Stockholders' Deficit (Details) - USD ($)	Jan. 14, 2019	Aug. 08, 2018	Jan. 30, 2020	Aug. 28, 2018	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Sep. 18, 2018
Stockholders' Deficit (Textual)
Preferred stock, authorized (in Shares)					10,000,000		10,000,000	10,000,000
Preferred stock, par value (in Dollars per share)					$ 0.001		$ 0.001
Common stock, authorized (in Shares)					200,000,000		200,000,000
Common stock, par value (in Dollars per share)					$ 0.001		$ 0.001
Deemed shares (in Shares)					19,383,794
Value of share issued for services				$ 5,001	$ 10,002	$ 561
Aggregate fair value of options			$ 51,757
Dividend rate					0.00%
Option [Member]
Stockholders' Deficit (Textual)
Option, exercise price (in Dollars per share)					$ 0.75
Remaining stock options will be amortized					$ 52,523
Advisor [Member] \| Four Month Agreement [Member]
Stockholders' Deficit (Textual)
Value of common stock issued				$ 6,667	$ 3.00
Number of share issued for services (in Shares)				1,667
Share price (in Dollars per share)				$ 3
Advisor [Member] \| Issue Price One [Member] \| One Year Agreement [Member]
Stockholders' Deficit (Textual)
Value of common stock issued		$ 5,000
Number of common stock issued (in Shares)		6,667
Number of share issued for services (in Shares)		1,667
Share price (in Dollars per share)					$ 3.00
Value of share issued for services		$ 5,001
Board of Directors Chairman [Member] \| Option [Member]
Stockholders' Deficit (Textual)
Share price (in Dollars per share)	$ 0.042
Number of shares purchase for issuance of options (in Shares)	800,000
Description of options vesting period	The options have an exercise price of $0.75 per share which will vest over a 24-month period as follows: 25% (or 200,000 and 50,000, respectively) shall vest six months after the grant date with the remaining options will vest on a monthly basis at a rate of 1/24th per month.
Option, exercise price (in Dollars per share)	$ 0.75
Vesting period	24 months
Expiration date	Jan. 14, 2029
Aggregate fair value of options	$ 17,111
Expected life (years)	10 years
Volatility rate	77.00%
Risk free interest rate	2.71%
Dividend rate	0.00%
Exercise price (in Dollars per share)	$ 0.75
Stock option expense					$ 1,595		$ 10,432
Mr. Vadim Sakharov [Member]
Stockholders' Deficit (Textual)
Number of common stock issued (in Shares)	200,000
Boris Goldstein [Member] \| Option [Member] \| Employment Agreement [Member]
Stockholders' Deficit (Textual)
Share price (in Dollars per share)			$ 0.12
Number of shares purchase for issuance of options (in Shares)			800,000
Option, exercise price (in Dollars per share)			$ 0.75
Expiration date			Jan. 30, 2030
Volatility rate			76.00%
Risk free interest rate			1.57%
Exercise price (in Dollars per share)			$ 0.75
Stock option expense					$ 4,319
Jesse W. Crowne [Member] \| Option [Member] \| Employment Agreement [Member]
Stockholders' Deficit (Textual)
Expected life (years)			10 years